In recent weeks, shares of MET pulled back to $44.50. Not only is it oversold at its lower Bollinger Band, but it’s excessively oversold on RSI, MACD, and on Williams’ %R. Plus, there’s a lot to like here. It earned $1.7 billion, or $1.77 a share, in its most recent quarter, compared with $845 million, or 83 cents a share, in the second quarter of 2018.
Adjusted, Metlife earned $1.3 billion, or $1.38 a share, compared with $1.3 billion, or $1.30 a share, a year ago. However, revenue did f...
Already a member? Login below, or click here to register now for free.